Search Results - "ZANDER, AXEL R."
-
1
Risk models predicting survival after reduced-intensity transplantation for myelofibrosis
Published in British journal of haematology (01-04-2012)“…Summary To define a prognostic model for predicting outcome of reduced‐intensity allogeneic stem cell transplantation (RIC‐ASCT) for myelofibrosis we evaluated…”
Get full text
Journal Article -
2
Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine
Published in Journal of cellular physiology (01-10-2007)“…Human bone marrow mesenchymal stromal cells (hMSC) are currently investigated for a variety of therapeutic applications. However, most expansion protocols…”
Get full text
Journal Article -
3
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV
Published in Blood (11-03-2010)“…The role of allogeneic stem cell transplantation in chronic myeloid leukemia is being reevaluated. Whereas drug treatment has been shown to be superior in…”
Get full text
Journal Article -
4
Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis
Published in Blood (04-11-2010)“…Allogeneic stem cell transplantation (ASCT) after reduced-intensity conditioning has become a reasonable treatment option for patients with advanced…”
Get full text
Journal Article -
5
Radiation rescue: mesenchymal stromal cells protect from lethal irradiation
Published in PloS one (05-01-2011)“…Successful treatment of acute radiation syndromes relies on immediate supportive care. In patients with limited hematopoietic recovery potential, hematopoietic…”
Get full text
Journal Article -
6
Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study
Published in Psycho-oncology (Chichester, England) (01-07-2013)“…Background Owing to its neurotoxicity, allogeneic hematopoietic stem cell transplantation (HSCT) carries risks for cognitive impairment. In this multicenter…”
Get full text
Journal Article -
7
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting
Published in British journal of haematology (01-10-2012)“…Summary Thirty myelofibrosis patients (21 males, nine females) with relapse (n = 27) or graft‐rejection (n = 3) after dose‐reduced allografting underwent a…”
Get full text
Journal Article -
8
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients
Published in Experimental hematology (01-10-2010)“…Objective The interaction of multiple myeloma (MM) with its bone marrow (BM) microenvironment is important for the homing pattern, survival, and proliferation…”
Get full text
Journal Article -
9
Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use
Published in Experimental hematology (01-12-2004)“…Mesenchymal stem cells (MSC) are promising candidates for cell-based therapies. One major obstacle for their clinical use is the biosafety of fetal calf serum…”
Get full text
Journal Article -
10
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
Published in Journal of hematology and oncology (24-06-2017)“…Primary refractory acute myeloid leukemia (PRF-AML) is associated with a dismal prognosis. Allogeneic stem cell transplantation (HSCT) in active disease is an…”
Get full text
Journal Article -
11
Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma
Published in Clinical cancer research (15-02-2009)“…Purpose: Reliable data on the persistence of tumor expression of cancer-testis (CT) antigens over time and consequent analyses of the effect of CT antigen…”
Get full text
Journal Article -
12
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
Published in Blood (01-02-2007)“…Immunotherapies using cancer-testis (CT) antigens as targets represent a potentially useful treatment in patients with multiple myeloma (MM) who commonly show…”
Get full text
Journal Article -
13
Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide
Published in Leukemia research reports (01-01-2023)“…Allogeneic stem cell transplant can have high morbidity and mortality in patients with myelofibrosis (MF) and multiple myeloma (MM). This phase 2 study used a…”
Get full text
Journal Article -
14
Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells
Published in Haematologica (Roma) (01-05-2010)“…Multiple myeloma is a life-threatening disease and despite the introduction of stem cell transplantation and novel agents such as thalidomide, lenalidomide,…”
Get full text
Journal Article -
15
Liver-specific gene expression in mesenchymal stem cells is induced by liver cells
Published in World journal of gastroenterology : WJG (07-08-2005)“…AIM: The origin of putative liver cells from distinct bone marrow stem cells, e.g. hematopoietic stem cells or multipotent adult progenitor cells was found in…”
Get full text
Journal Article -
16
Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine Conditioning
Published in Journal of clinical oncology (10-07-2010)“…Treosulfan was introduced recently as a conditioning agent for allogeneic blood stem-cell transplantation. The favorable nonhematologic toxicity profile at 3 x…”
Get full text
Journal Article -
17
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma
Published in Haematologica (Roma) (01-10-2011)“…To date, multiple myeloma remains an incurable malignancy due to the persistence of minimal residual disease in the bone marrow. In this setting, monoclonal…”
Get full text
Journal Article -
18
Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation in Adult Patients With Acute Lymphoblastic Leukemia: No Difference in Related Compared With Unrelated Transplant in First Complete Remission
Published in Journal of clinical oncology (15-07-2004)“…The role of unrelated allogeneic stem-cell transplantation in acute lymphoblastic leukemia (ALL) patients is still not clear, and only limited data are…”
Get full text
Journal Article -
19
Hepatocytic differentiation of mesenchymal stem cells in cocultures with fetal liver cells
Published in World journal of gastroenterology : WJG (21-04-2006)“…To investigate the hepatocytic differentiation of mesenchymal stem cells (MSCs) in co-cultures with fetal liver cells (FLC) and the possibility to expand…”
Get full text
Journal Article -
20
Detection of Virulence-Associated Genes Not Useful for Discriminating between Invasive and Commensal Staphylococcus epidermidis Strains from a Bone Marrow Transplant Unit
Published in Journal of Clinical Microbiology (01-12-2004)“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article